Federal award
TRIUS THERAPEUTICS, INC.
HDTRA110C0004
Contract
Obligated and Ceiling
- Obligated (net)
- $7,272,905.00
- Ceiling (potential value, not spending)
- $29,009,499.00
- Current value
- $7,272,906.00
- Gross positive obligations
- $7,272,906.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TRIUS THERAPEUTICS, INC. · MCPHH5DJ3GR6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CUBIST PHARMACEUTICALS, INC. · GW3PT4JEHQD5
- Awarding agency
- Department of War · sub-agency 9761 · office HDTRA1
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- HDTRA110C0004
- Award type code
- D
- Actions
- 8 · Apr 19, 2010 to Apr 20, 2017
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History8
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 20, 2017 | FY2017 | P00006 | C | −$1.00 | — |
| Nov 5, 2015 | FY2016 | ARZ998 | M | $0.00 | — |
| Feb 22, 2012 | FY2012 | P00005 | M | $0.00 | — |
| Sep 30, 2011 | FY2011 | P00004 | C | $1,607,430.00 | — |
| Jun 24, 2011 | FY2011 | P00003 | C | $1,500,000.00 | — |
| Sep 7, 2010 | FY2010 | P00002 | M | $0.00 | — |
| Sep 1, 2010 | FY2010 | P00001 | G | $0.00 | — |
| Apr 19, 2010 | FY2010 | 0 | — | $4,165,476.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.